Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-label Evaluation of Treatment Satisfaction, Tolerability, Safety and Preference for Sumavel DosePro for Treatment of Migraine in Subjects Currently Treated With Triptans

NCT01016834 is registered in ClinicalTrials.gov with Zogenix, Inc. as lead sponsor.

NCT NCT01016834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01016834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-label Evaluation of Treatment Satisfaction, Tolerability, Safety and Preference for Sumavel DosePro for Treatment of Migraine in Subjects Currently Treated With Triptans
Lead sponsor
Zogenix, Inc.
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2009
Completion date
April 30, 2010
Enrollment
246 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

migraine